Hainan Yedao Announces RMB 1.7 Billion Fundraising for Telemedicine Platform to Build Integrated 'Greater Health Industry' Ecosystem
Hainan Haiyao Co., Ltd. announced on March 9 that it plans to raise RMB 1.7 billion for a telemedicine service platform project, aiming to establish an integrated “big health industry” business system encompassing pharmaceuticals, medical devices, and healthcare services.
The announcement stated that the Telemedicine Service Platform project, leveraging cloud computing and cloud storage, the Internet of Things (IoT), mobile internet, and remote medical diagnosis and monitoring analysis technologies, integrates software systems, IoT-enabled medical device terminals, and high-quality medical resources. It will establish a remote ECG diagnosis and treatment platform, a remote B-scan ultrasound diagnosis and treatment platform, a remote DR (Digital Radiography) diagnosis and treatment platform, a remote pathology analysis platform, a remote consultation platform, a remote pharmaceutical care service platform, a remote medical education platform, and a backend support system for the cloud platform. These initiatives aim to provide remote diagnostic and therapeutic services to primary healthcare institutions, facilitate the decentralization of provincial medical technical resources, and effectively enhance the professional expertise and service capacity of primary healthcare institutions.
The announcement further stated that the telemedicine service platform project will be primarily implemented in Sichuan, Chongqing, Hunan, Jiangsu, Hubei, Jiangxi, Guangxi, Hainan, Tibet, Yunnan, Henan, and Hebei. It is evident that the project’s coverage focuses mainly on the central and western regions of China, which are characterized by relatively lower levels of urbanization and weaker healthcare resources. Telemedicine will effectively address the shortage of high-quality medical resources and alleviate the difficulties faced by residents in accessing medical care in these areas.
It is understood that Hainan Haiyao Co.,Ltd has been actively deploying its telemedicine business:
In May 2015, Hainan Haiyao Co., Ltd. increased its capital investment in Chongqing Adtech Science&Technology Co., Ltd. by RMB 31.05 million, acquiring a 28.65% equity stake. Chongqing Adtech’s core business includes regional health information platforms, hospital informatization platforms, and virtual hospitals, and it operates the mobile medical health cloud service platform “Yishitong.”
In June 2015, Hainan Haiyao Co., Ltd. announced the establishment of the “Chunfeng Fund” in partnership with Chunfeng Investment, contributing RMB 50 million from its own funds to focus on equity investments in mobile healthcare and health management. Chunfeng Investment is an investment fund spearheaded by Chunyu Yisheng, a leading enterprise in the mobile healthcare sector, and specializes in venture capital within the mobile healthcare industry.
In August 2015, Hainan Haiyao Co., Ltd. announced its plan to inject RMB 10 million into Jinshengda Air Hospital and become its largest shareholder (holding a 25% stake). Jinshengda’s core business is telemedicine. Its “Air Hospital Network” has already launched telemedicine-related services in Hunan Province, established remote medical collaborations with nearly 150 healthcare institutions, and completed over 100,000 telemedicine cases, thereby accumulating extensive experience in the field of telemedicine.
At the end of 2015, Hainan Haiyao launched the Haiyao Grand Health website, which focuses on telemedicine and health management. The company has since signed framework cooperation agreements with several medical institutions, including China-Japan Friendship Hospital, Chongqing Yubei District People’s Hospital, the Second Affiliated Hospital of Chongqing Medical University, and Chongqing Fire Corps Hospital, to jointly develop telemedicine services.
However, Hainan Haiyao’s medical layout does not stop at telemedicine. According to the company’s “Future Strategic Development Plan (2016–2020),” Hainan Haiyao will take investment in telemedicine service platforms and health management service platforms as its entry point, integrate high-quality medical service resources, and form a “big health industry” business system that integrates pharmaceuticals, medical devices, and medical services.